NCT01048281Recruiting
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
Source: ClinicalTrials.gov · Last updated 18 Dec 2025
Brief summary (registry, in English)
Our research of the biology of upper gastrointestinal cancers involves the study of tissue samples and cells from biopsies of persons with gastric or esophageal cancer or blood samples from upper gastrointestinal cancer patients and persons at high inherited risk for these cancers. We hope to learn the role genes and proteins play in the development of gastric and esophageal cancer.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 11 Jan 2010
- Start date
- 1 Aug 2002
- Primary completion date
- 31 Jan 2099
- Lead sponsor
- Stanford University
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT01048281
What you commit to
- Study type: Observational
- Planned participants: 100
- From 1 Aug 2002 to the primary completion date, 31 Jan 2099
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- No family or personal history of gastric or esophageal cancer
Other
- Under 18
Who the study is looking for
- Over 18
- Diagnosed with gastric or esophageal cancer OR at an increased hereditary risk for upper GI cancer
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Stanford University School of Medicine Coordinator of this site? Confirm its status | Stanford | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.